Halozyme (HALO) is up 11% to $50.99 in pre-market trading.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EVO:
- Halozyme withdraws proposal to acquire Evotec
- Halozyme withdraws proposal to acquire Evotec for EUR 11.00 per share in cash
- Spirit enters into bankruptcy proceedings, CVS names new directors: Morning Buzz
- Halozyme provides update on proposal to combine with Evotec
- Berkshire reveals stake in Domino’s, Alibaba reports mixed Q2: Morning Buzz